By Nikki Kean
Investigators from the FDA have discovered records of 4,202 adverse events related to compounded products, none of which had ever been reported to the agency, according to a new report published in JAMA Internal Medicine (2019 Sep 9. [Published online]).
The reports, kept in a company-generated data file, concerned the possible association of compounded hormone pellets marketed by BioTE Medical (BioTE) with the development of cancer, stroke, heart attack, deep vein thrombosis